Introduction
Marginal zone B cell non-Hodgkin's lymphoma of the mucosa-associated lymphoid tissue type (MALT-type NHL) is a distinct lymphoma entity with characteristic clinicopathologic features.
1,2 MALT-type NHL arise as primary extranodal lymphomas from lymphoid tissues induced in organs by inflammatory stimuli such as chronic infection or autoimmune disease. 3, 4 The fact that 70% to 83% of gastric MALT-type NHL regress upon eradication of Helicobacter pylori 5, 6 suggests its dependence on growth stimuli provided by chronic bacterial inflammation. The genetic mechanisms underlying the transformation of this lymphoid tissue leading to the development of MALT-type NHL are poorly defined.
Chromosome banding analyses disclosed the translocation t(11;18)(q21;q21) to be the most frequent structural chromosome aberration in 30% to 40% of MALT-type NHL. 7, 8 This translocation was initially described by Levine et al 9 in two extranodal lymphomas and subsequently found in several cases of MALT-type NHL or lymphomas with predominantly extranodal involvement. [10] [11] [12] Interphase cytogenetic analysis of a larger series of MALT-type lymphomas as well as splenic and nodal marginal zone B cell non-Hodgkin's lymphoma by fluorescent in situ hybridisation (FISH) revealed the translocation t (11;18) exclusively in primary extranodal MALT-type lymphomas. Moreover, the t(11;18) was not found in a series of 34 extranodal large B cell lymphomas (LBL). 13 The high specificity for a distinct tumour type, the high frequency and the fact that this translocation was invariably found as the sole karyotypic abnormality suggest a pathogenic role of a gene rearrangement at the 11q21 and 18q21 breakpoints in MALTtype NHL.
Towards the identification of the genes affected by this translocation, physical mapping and characterisation of the breakpoint region in 18q21 was performed. Analysing the breakpoint region (BPR) on chromosome 18 the new MALT1 gene was identified and found to be fused to gene API2 on chromosome 11. [14] [15] [16] [17] [18] In the current study, we independently performed a systematic analysis of the 11q21 BPR in cases of MALT-type NHL carrying the t (11;18) . On the basis of one PAC clone spanning the breakpoint, the gene involved on 11q21 and the translocation partner on 18q21 were identified by rapid amplification of cDNA ends (RACE). Since it is still a matter of debate whether there is progression from MALTtype lymphoma to large B cell lymphoma or if different clones with differing growth characteristics arise de novo, in addition to MALT-type NHLs a series of extranodal LBLs was examined for the presence of the translocation t(11;18) and for variations in the molecular breakpoints applying RT-PCR and cDNA sequencing.
Materials and methods

Specimens
Twenty-four MALT-type lymphomas and 10 LBL with or without low-grade component diagnosed according to the criteria of the REAL classification 2 were collected as routinely snap frozen tissues from the Institute of Pathology, Wü rzburg. A subset of 14 MALT-type NHL and nine LBL have previously been investigated by cytogenetic analysis and/or dual-colour interphase FISH for the t(11;18)(q21;q21): Nine MALT-type lymphomas but none of the LBL analysed harboured the translocation (Table 1) .
8,13
Molecular cytogenetic analyses
Cells were obtained by mechanical disaggregation of tumour tissue and harvested either directly, after short-term culture, or after stimulation with CD40 ligand. 8, 19 Analysis of the 11q21 BPR was performed by dual-colour FISH as previously detailed for 11q aberrations. 13 YAC clones 801B3, 805C4, 878C12, 963C8 and 966E4 (obtained from the Centre d'Etude du Polymorphisme Humain (CEPH) Paris, France) were selected from a sequence-tagged site (STS)-based YAC map spanning chromosome bands 11q14-q24. 20, 21 the Resource Center/Primary Database of the German Human Genome Project, Berlin, Germany). The chromosomal localisation of the PACs was confirmed by FISH and a physical map of the respective DNA fragments was established applying filter hybridisation, modified as described by Church and Gilbert. 23 Detailed analysis of the map was performed using extended DNA fibers as targets according to the DIRVISH protocol (see Figure 1) . 24 STS markers (www-genome.wi.mit.edu) as well as known genes and cDNAs (www. ncbi.nlm.nih.gov/genemap98/) of the 11q21 BPR were tested by PCR for their localisation in the identified DNA fragments. Amplification of API1 and API2 genomic sequences was performed with primer pairs NIB1866a/b, WI-18122a/b and A007H38a/b, G43764a/b, respectively (Table 2) .
RACE experiments
Total RNA from tumour samples was isolated with the Trizol reagent (Life Technologies, Eggenstein, Germany) and RNA/DNA Kit (QIAGEN, Hilden, Germany). The 3Ј-rapid amplification of cDNA ends (3Ј-RACE) was performed using the SMART RACE cDNA amplification kit (Clontech, Palo Alto, CA, USA). First-strand cDNA was synthesised with MMLV reverse transcriptase using the 3Ј-RACE cDNA synthesis primer. RACE products were amplified with API2 genespecific primers CR1A and CR3A in combination with the Universal Primer Mix and reamplified with the inner primers CR1N and CR3N and the 'Nested Universal Primer' ( Table 2) . The 3Ј-RACE products were cloned into the pCR2-XL-TOPO vector (Invitrogen, Groningen, The Netherlands), and the plasmid clones were analysed by DNA sequencing (see below).
Reverse-transcription (RT)-PCR analysis
First-strand cDNA was synthesised from total RNA (1 g) with MuLV reverse transcriptase using random hexamers and oligo d(T) primers (GeneAmp RNA PCR System; Perkin-Elmer, Weiterstadt, Germany) in a reaction volume of 20 l. Primer sets API2-2A/MALT2B and API2-1A/MALT9B were used to amplify the API2-MALT1 fusion transcripts. In case of low abundance
Figure 1
Schematic illustration of the chromosomal region in band 11q21 involved in the t(11;18)(q21;q21) translocation. (a) Genetic map with markers mapping to the region (distances are not drawn to scale). (b) YAC contig: the overlapping region of the YAC clones 801B3 and 878C12 is limited by the markers D11S4478 and D11S4471 (25) . The 11q21 breakpoint of the t(11;18) in all four cases analysed occurred in the genomic region shared by YAC 801B3 and YAC 878C12 as indicated by a split of the corresponding FISH signal (see Figure 2 ). (c) PAC contig with P704N16684, P704B23689 and P704L2225 centromeric of the breakpoint, with P704B0697 and P704E15220 telomeric of the 11q21 breakpoint, and P704N201052 (containing API1 and API2) which is split in t(11;18)(q21;q21)-positive cases.
Table 2
Oligonucleotide primers for PCR amplification and sequence analyses
Primer
Gene Oligonucleotide sequence (5Ј-3Ј) G43764a  API2  CTGTTTGTTTTTAAAGGCAGGG  G43764b  API2  ATACCGGGAACATGAAGCC  CR1A  API2  TTATTATGTGGGTAACAGTGATGATGTC  CR3A  API2  TACTTGAACAGCTGCTATCCACATCAG  CR1N  API2  TGTGGGTAACAGTGATGATGTCAAATGC  CR3N  API2  TGAACAGCTGCTATCCACATCAGACAG  API2-1A  API2  ACAGGAGTTCATCCGTCAAG  API2-2A  API2  GCCCGCTTTAAAACATTCTTTAA  API2-3A  API2  GAGAGAGAAAGAGCAACTGAG  API2-4A  API2  GTGTTAGACTTACTCAATGCAG  API2-1B  API2  AGGAAACCAAATTAGGATAAAAG  MALT1A  MALT1 GCCTCAGTTGCCTAGACCTG  MALT2A  MALT1 CCAGCCTGTGTCTGCTGAAG  MALT2B  MALT1 GATTCCATTTGCCAATCCAG  MALT6B  MALT1 GGTGCTCCCGGTAATTCAT  MALT8B  MALT1 AGGGCAACCTTGTCCTTCGC  MALT9B MALT1 ACCATGAAGCTGTTCCCAAA GAPDHfor1 GAPDH TGAAGGTCGGAGTCAACGGATTTGGT GAPDHfor2 GAPDH GTGGAAGGACTCATGACCACAGTC GAPDHrev GAPDH CATGTGGGCCATGAGGTCCACCAC Primer sets NIB1866a/b, WI-18122a/b, A007H38a/b, G43764a/b were derived from The Genome Database (http://gdbwww.gdb.org/gdb/). Primers CR1A, CR3A, CR1N, CR3N, API2-1A, API2-2A, API2-3A, API2-4A, API2-1B and MALT2B, MALT6B, MALT8B, MALT9B, MALT1A, MALT2A were designed on the basis of cDNA sequence data from the API2 gene (GenBank accession No. NMF001165) and the MALT1 gene (GenBank accession No. NMF006785). Primer pair GAPDHfor1/rev has previously been described. 42 Leukemia of the fusion transcript the primary amplification products (1:1000 in H 2 O) were reamplified with nested primer sets API2-1A/MALT9B, API2-4A/MALT6B and API2-3A/MALT8B. Primer pairs MALT1A/G43764a and MALT1A/API2-1B were used in combination with inner primers MALT2A/API2-1B to investigate the expression of a MALT1-API2 fusion transcript. As a positive control, RT-PCR amplifications of the GAPDH transcript with primer pairs GAPDHfor1/GAPDHrev and GAPDHfor2/GAPDHrev were performed. As negative controls, cDNA synthesised from total RNA of healthy individuals as well as from lymph node and spleen Poly A+ RNA (Clontech) were employed. All primer sequences are detailed in Table 2 . RT-PCRs were carried out with 1 l cDNA and 5 pmol of each primer in the presence of 5 nmol dNTPs, 0.25 l 'Advantage cDNA Polymerase Mix' (Clontech) and supplied buffer in a total volume of 25 l. Denaturation at 94°C for 2 min was followed by 35 cycles of amplification (94°C for 20 s, 60-62°C for 20 s, 72°C for 40-110 s).
DNA sequence analysis
Direct sequencing of PCR products and sequence analysis of plasmid inserts was done by cycle sequencing with ABI PRISM BigDye Terminator chemistry (Perkin-Elmer) followed by electrophoresis on a Perkin-Elmer ABI-377 automated sequencer. Analysis of the sequence data was performed by BLAST search of nucleic acid and protein sequence databases (http:www.ncbi.nlm.nih.gov/BLAST/).
Protein domain prediction
Sequences of the API2 and MALT1 translation products as well as of the putative API2-MALT1 fusion protein were analysed using the Pfam algorithm (www.sanger.ac.uk/Software/Pfam/search.shtml).
Results
Characterisation of the chromosome 11 breakpoint region
Towards the identification of the 11q21 breakpoint, interphase nuclei of four MALT-type lymphomas (No. 2, No. 5, No. 6, No. 22) that were previously shown to carry the translocation t(11;18)(q21;q21) 8 were analysed by dual-colour FISH with a contig of five YACs covering the BPR. The signals of the differentially labelled YACs 966E4/963C8 (pooled) and 805C4 were separated in nuclei of t(11;18)(q21;q21)-positive cases pointing to the localisation of the breakpoint in the intervening chromosomal region. Consistently, FISH with YACs 801B3 and 878C12, localised between 966E4, 963C8 and 805C4, showed a split hybridisation signal which indicates that the breakpoint is localised in the overlapping region of these two YACs (Figures 1b and 2a) .
To further narrow the 11q21 breakpoint, a PAC contig was generated by hybridisation of Alu-PCR products of both breakpoint-spanning YACs to a gridded human genomic PAC library. FISH experiments on t(11;18)-positive tumour cases in combination with filter hybridisation, STS-PCR and fiber FISH data allowed for the generation of a set of contiguous PAC DNA fragments spanning the breakpoint (Figures 1c and 2c ). The PAC N201052 was shown by FISH to exhibit a split signal in all four t(11;18)-positive cases (Figure 2b) . Thus, the breakpoint could be confined to a region about 145 kb in size.
Two apoptosis-associated genes, API2 and API1, 25, 26 are localised within the BPR covered by PAC N201052 (http://www3.ncbi.nlm.nih.gov/genemap98) which was confirmed by gene-specific PCR analysis. Presuming that these genes are directly affected by the translocation, we attempted to identify the fusion partner on chromosome 18q by performing 3Ј-RACE experiments on reverse transcribed RNA isolated from three tumours (No. 1, No. 3, No. 6) that were shown by banding analysis and/or FISH to have the translocation t(11;18)(q21;q21). In all three cases, amplification with API2-specific forward primers CR1A/CR1N and CR3A/CR3N Figure 1) . revealed transcripts the sequences of which diverged from the API2 cDNA sequence (GenBank acc. No. NMF001165) starting at nucleotide 1325. A BLAST search of the GenBank sequence database showed that the sequences immediately downstream of this position were homologous to two overlapping cDNA clones (IMAGE: 1420842 3Ј and IMAGE: 649271 5Ј, GenBank acc. Nos AA826328 and AA214173) and to the recently identified MLT/MALT1 gene, further referred to as MALT1 (GenBank acc. Nos NMF006785, AB026118). [15] [16] [17] No reciprocal MALT1-API2 transcript was detected by RT-PCR analysis.
Analysis of API2-MALT1 fusion transcripts in MALTtype lymphoma and LBL
The presence of an API2-MALT1 fusion transcript in the three cases described above was confirmed by RT-PCR amplification with primers flanking the API2-MALT1 junction. The same RT-PCR assay was used to analyse an additional 21 MALT-type lymphomas, six of them with a microscopically detected t(11;18)(q21;q21) ( Table 1 ). In all nine cases (Nos 1-6, Nos 22-24) that were shown by chromosome banding and/or FISH to have a t(11;18)(q21;q21), a fusion mRNA was detected. Furthermore, 4/5 tumours which were t(11;18) negative by FISH (based on the cut-off level of the applied interphase FISH assay, only specimens containing more than 3% of cells with alterations were scored positive by FISH 13 ) and 5/10 cases not analysed at the cytogenetic level, were clearly positive for an API2-MALT1 fusion transcript. Of note, only for two of the positive cases (No. 4, No. 19) amplifications with nested primer sets were necessary to achieve a positive PCR result and to amplify sufficient product for direct sequence analysis. In none of the 10 analysed extranodal LBL cases was a fusion transcript detected even though a nested PCR strategy was used. These results were confirmed by independent RT-PCR amplifications with different primer pairs. In all patient samples, control amplifications of the GAPDH transcript were performed (Figure 3) . As detailed in Figure 4 , five API2-MALT1 fusion variants were isolated. In all but one case, exon 7 of API2 was joined to MALT1 sequences, resulting in the retention of the three baculoviral inhibitor of apoptosis repeat (BIR) domains of API2 but the loss of the API2 caspase recruitment domain (CARD) domain and the RING motif from the predicted translation product. In case No. 24, exons 8 and 9 coding for the CARD domain were preserved in the fusion transcript. Four alternative MALT1 junctions originate from an interval of 609 bp within the MALT1 cDNA. In all instances, the fusion of MALT1 sequences occurred in frame and generated API2-MALT1 transcripts that all retain sequences homologous to immunoglobulin ␥ chain VDJ4 and the F22D3.6 gene product of Caenorhabditis elegans. [15] [16] [17] In addition to these regions, in seven cases one or both immunoglobulin-like C2 domains are contained in the C-terminal part of the predicted API2-MALT1 fusion protein. In all fusion transcripts, the MALT1 part did not contain nucleotides 926-958 of the cDNA sequence (GenBank acc. No. NMF006785). 16 The same feature has already been described for MALT1 cDNA clones (GenBank acc. No. AB026118). 15 The primer combinations API2-2A/MALT2B and API2-1A/MALT9B recognise API2 and MALT1 sequences that are preserved in all variants of the translocation-specific transcript identified so far. With an RT-PCR approach based on these primers we have, therefore, established a suitable diagnostic tool for the sensitive detection of the API2-MALT1 fusion. The combination of both primer pairs in a nesting assay further enhances the sensitivity and allows the detection of small amounts of transcripts (as shown for cases 4 and 19) . The feasibility of this RT-PCR approach to diagnose all known API2-MALT1 fusions has been proven by FISH analysis with YAC and PAC probes isolated in this study (966E4, 805C4 flanking YAC; N16684, E15220 flanking PAC; 878C12 breakpoint spanning YAC; N201052 breakpoint spanning PAC).
Discussion
In the present study, API2 on chromosome 11 and MALT1 on chromosome 18 were identified as genes directly affected by the translocation t(11;18)(q21;q21). The resulting fusion transcript consisting of API2 sequences (5Ј) and MALT1 sequences Leukemia (3Ј) was analysed in a series of 24 low-grade MALT-type lymphomas, nine of them with a microscopically detected t(11;18)(q21;q21). In all cases with a translocation and five of 10 tumours that had not been analysed cytogenetically, an API2-MALT1 fusion transcript was detected. Notably, four lymphomas determined as t(11;18) negative by FISH were shown to express the chimerical transcript. This is attributed to the limited sensitivity of FISH in identifying small subsets of cells carrying chromosome alterations. The frequency of the t(11;18)-associated gene rearrangement in low-grade MALTtype lymphomas may, therefore, be higher than originally anticipated based upon cytogenetic data. It is noteworthy that the API2-MALT1 gene fusion was not restricted to gastric tumours but was also detected in MALT-type lymphomas localised in lung, thyroid gland and salivary gland. Our data are in agreement with very recent findings of this rearrangement in lung and colon lymphoma. 27, 28 Since MALT is known to be associated with inflammatoric processes and the characteristic fusion API2-MALT1 is found not only in MALT-type lymphoma of the stomach which is strongly associated with Helicobacter pylori, 29 the gene rearrangement may arise from inflammatory processes independent of Helicobacter pylori.
Two lines of evidence argue for API2-MALT1 fusion transcripts acting as the tumorigenic factor caused by the translocation t(11;18)(q21;q21): (1) [15] [16] [17] 27, 28, 31 This high specificity argues for API2 and not the closely related API1 to constitute the relevant gene affected by the translocation t(11;18). (2) Expression of a reciprocal transcript MALT1-API2 was not detectable.
The mechanism by which an API2-MALT1 fusion might act is unknown. However, with respect to the known anti-apoptotic function of API2 an interference with the regulation of apoptosis is conceivable. API2 belongs to the evolutionary conserved inhibitor of apoptosis (IAP) family of proteins, all of which display the ability to suppress programmed cell death. API2 has been implicated in both CD95-induced apoptosis as well as cell death pathways induced by the tumor necrosis factor (TNF) through direct inhibition of caspases 3, 7 and 9 and interaction with the TNF receptor-associated factors TRAF1 and TRAF2, respectively. 25, 32, 33 Structurally, IAP proteins are characterised by the presence of up to three BIR motifs, a carboxy-terminal RING domain and, exclusively in API2 and API1, a CARD domain located between the BIR and RING domains (Figure 4 ; for review see Ref. 26 ). 26 The chimeric transcripts detected in this study predict translation products that retain the three BIR domains of API2 in all cases, but lack the CARD and RING domains. As an exception, in one case similarly to three single cases reported by Motegi et al 27 and Remstein et al 28 the CARD domain was preserved. Although the retention of this domain could influence the caspase-binding affinity of a fusion protein, the pathogenic significance of this rare variant is not known. Interestingly, it was demonstrated that truncated API2 proteins containing the BIR domains solely retain their ability to inhibit caspases and to suppress CD95-induced apoptosis. 32 Moreover, mutation analyses of the Drosophila homologue D-IAP1 showed that its death-preventing activity localises to the amino-terminal BIR repeats and that the removal of the RING domain actually enhanced the ability to suppress developmental cell death. 34, 35 Therefore, the replacement of the carboxy-terminal part of API2 by MALT1 sequences is expected not to substantially disturb the anti-apoptotic functions, which is attributable to API2, but rather result in a modification of its functional properties. Although the function of the MALT1 gene is not yet known, it may be hypothesised that the carboxy-terminal portion of MALT1 affects the regulation of API2 and/or confers new binding properties on the protein. In fact, immunoglobulin-like C2 domains as contained in MALT1 are thought to mediate protein-protein interactions. However, since one or both C2 domains were only present in 39% of the fusion products, these domains may not be crucial for an active fusion protein. The functional properties of the carboxy-terminal part of MALT1 showing homology to the C. elegans gene F22D3.6 and to the murine VDJ4 sequence are not clear.
In support of the concept that MALT-type lymphoma progresses to large B cell lymphoma, identical immunoglobulin light and heavy chain gene rearrangements were reported in low-grade and simultaneously present high-grade lymphomas indicating a clonal relationship in these cases. [36] [37] [38] In contrast, we previously demonstrated a multifocal and multiclonal development of lymphoma in different infiltrates of the gastric mucosa. 39, 40 In the present study, none of the LBLs with or without a low grade component analysed expressed an API2-MALT1 fusion transcript. These findings are in accordance with previous studies, which revealed the translocation t(11;18) to be a characteristic feature of low-grade MALT-type tumours but not to be present in other MZBL subtypes or in (extranodal) LBL. 8, 13 Moreover, Baens et al 31 detected the expression of API2-MALT1 fusion transcripts exclusively in gastric marginal zone lymphomas that did not contain a large cell component. The observation that the translocation t(11;18)(q21;q21) is restricted to low-grade MALT-type lymphoma supports the view that high-grade large B cell lymphoma arise de novo rather than evolve from MALTtype lymphoma.
In conclusion, in this study we characterised a variety of API2-MALT1 gene fusions in a series of MALT-type lymphomas. The established RT-PCR assay has been proven a suitable method for the detection of this gene rearrangement. In combination with FISH analysis employing the isolated fragments that cover the breakpoint region on chromosome 11 this sensitive assay provides a powerful diagnostic tool for the further evaluation of the meaning of this genetic aberration.
